Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:50 UTC |
---|
Update Date | 2022-03-07 02:51:44 UTC |
---|
HMDB ID | HMDB0014772 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Sulfacetamide |
---|
Description | Sulfacetamide is only found in individuals that have used or taken this drug. It is an anti-infective agent that is used topically to treat skin infections and orally for urinary tract infections. [PubChem]Sulfacetamide is a competitive inhibitor of bacterial para-aminobenzoic acid (PABA), an essential component for bacterial growth (according to the Woods-Fildes theory). The inhibited reaction is necessary in these organisms for the synthesis of folic acid. |
---|
Structure | CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11) |
---|
Synonyms | Value | Source |
---|
Acetosulfamine | ChEBI | N'-acetylsulfanilamide | ChEBI | N-((p-Aminophenyl)sulfonyl)acetamide | ChEBI | N-(p-Aminobenzenesulfonyl)acetamide | ChEBI | N-[(p-Aminophenyl)sulfonyl]acetamide | ChEBI | N-Acetyl-4-aminobenzenesulfonamide | ChEBI | N-Acetylsulfanilamide | ChEBI | N-Sulfanilylacetamide | ChEBI | N-Sulphanilylacetamide | ChEBI | N(1)-Acetyl-4-aminophenylsulfonamide | ChEBI | N(1)-Acetylsulfanilamide | ChEBI | p-Aminobenzenesulfonacetamide | ChEBI | p-Aminobenzenesulfonoacetamide | ChEBI | Sulfacetamida | ChEBI | Sulfacetamidum | ChEBI | Sulfanilazetamid | ChEBI | Sulphacetamide | ChEBI | Sulphacetamidum | ChEBI | Acetosulphamine | Generator | N'-acetylsulphanilamide | Generator | N-((p-Aminophenyl)sulphonyl)acetamide | Generator | N-(p-Aminobenzenesulphonyl)acetamide | Generator | N-[(p-Aminophenyl)sulphonyl]acetamide | Generator | N-Acetyl-4-aminobenzenesulphonamide | Generator | N-Acetylsulphanilamide | Generator | N(1)-Acetyl-4-aminophenylsulphonamide | Generator | N(1)-Acetylsulphanilamide | Generator | p-Aminobenzenesulphonacetamide | Generator | p-Aminobenzenesulphonoacetamide | Generator | Sulphacetamida | Generator | Sulphanilazetamid | Generator | AK-sulf | HMDB | Ceta sulfa | HMDB | Monosodium salt, sulfacetamide | HMDB | Sodium, sulfacetamide | HMDB | Sulf-10 | HMDB | Sulfacetamida, colircusi | HMDB | Sulfacetamide sodium | HMDB | Sulfacetamide, monosodium salt, anhydrous | HMDB | Sulfacyl | HMDB | Sulfair | HMDB | Acetopt | HMDB | Albucid | HMDB | Belph 10 | HMDB | Bleph | HMDB | Sodium sulamyd | HMDB | Sulf 10 | HMDB | Sulfacetam, coliriocilina | HMDB | Acetylsulfanilamide | HMDB | Antébor | HMDB | Coliriocilina sulfacetam | HMDB | AK sulf | HMDB | Belph-10 | HMDB | Cetamide | HMDB | Colircusi sulfacetamida | HMDB | Isopto cetamide | HMDB | Sulamyd, sodium | HMDB | Sulfacetamide monosodium salt | HMDB | Sulfacil | HMDB |
|
---|
Chemical Formula | C8H10N2O3S |
---|
Average Molecular Weight | 214.242 |
---|
Monoisotopic Molecular Weight | 214.041212886 |
---|
IUPAC Name | N-(4-aminobenzenesulfonyl)acetamide |
---|
Traditional Name | sulfacetamide |
---|
CAS Registry Number | 144-80-9 |
---|
SMILES | CC(=O)NS(=O)(=O)C1=CC=C(N)C=C1 |
---|
InChI Identifier | InChI=1S/C8H10N2O3S/c1-6(11)10-14(12,13)8-4-2-7(9)3-5-8/h2-5H,9H2,1H3,(H,10,11) |
---|
InChI Key | SKIVFJLNDNKQPD-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aminobenzenesulfonamides. These are organic compounds containing a benzenesulfonamide moiety with an amine group attached to the benzene ring. |
---|
Kingdom | Organic compounds |
---|
Super Class | Benzenoids |
---|
Class | Benzene and substituted derivatives |
---|
Sub Class | Benzenesulfonamides |
---|
Direct Parent | Aminobenzenesulfonamides |
---|
Alternative Parents | |
---|
Substituents | - Aminobenzenesulfonamide
- Benzenesulfonyl group
- Aniline or substituted anilines
- Organic sulfonic acid or derivatives
- Organosulfonic acid or derivatives
- Sulfonyl
- Acetamide
- Aminosulfonyl compound
- Amino acid or derivatives
- Carboxylic acid derivative
- Organic oxide
- Organopnictogen compound
- Primary amine
- Organosulfur compound
- Organooxygen compound
- Organonitrogen compound
- Amine
- Carbonyl group
- Organic oxygen compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Aromatic homomonocyclic compound
|
---|
Molecular Framework | Aromatic homomonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 183 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 4.21 g/L | Not Available | LogP | -0.6 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Sulfacetamide,1TMS,isomer #1 | CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C1 | 2354.3 | Semi standard non polar | 33892256 | Sulfacetamide,1TMS,isomer #1 | CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C1 | 2220.2 | Standard non polar | 33892256 | Sulfacetamide,1TMS,isomer #1 | CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C1 | 2872.9 | Standard polar | 33892256 | Sulfacetamide,1TMS,isomer #2 | CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N)C=C1 | 2118.7 | Semi standard non polar | 33892256 | Sulfacetamide,1TMS,isomer #2 | CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N)C=C1 | 2094.6 | Standard non polar | 33892256 | Sulfacetamide,1TMS,isomer #2 | CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N)C=C1 | 3190.2 | Standard polar | 33892256 | Sulfacetamide,2TMS,isomer #1 | CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C1 | 2236.4 | Semi standard non polar | 33892256 | Sulfacetamide,2TMS,isomer #1 | CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C1 | 2259.3 | Standard non polar | 33892256 | Sulfacetamide,2TMS,isomer #1 | CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C)C=C1 | 2672.7 | Standard polar | 33892256 | Sulfacetamide,2TMS,isomer #2 | CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1 | 2242.2 | Semi standard non polar | 33892256 | Sulfacetamide,2TMS,isomer #2 | CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1 | 2338.2 | Standard non polar | 33892256 | Sulfacetamide,2TMS,isomer #2 | CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1 | 2698.3 | Standard polar | 33892256 | Sulfacetamide,3TMS,isomer #1 | CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1 | 2165.0 | Semi standard non polar | 33892256 | Sulfacetamide,3TMS,isomer #1 | CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1 | 2411.0 | Standard non polar | 33892256 | Sulfacetamide,3TMS,isomer #1 | CC(=O)N([Si](C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C)[Si](C)(C)C)C=C1 | 2563.8 | Standard polar | 33892256 | Sulfacetamide,1TBDMS,isomer #1 | CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1 | 2597.5 | Semi standard non polar | 33892256 | Sulfacetamide,1TBDMS,isomer #1 | CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1 | 2450.9 | Standard non polar | 33892256 | Sulfacetamide,1TBDMS,isomer #1 | CC(=O)NS(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1 | 2923.8 | Standard polar | 33892256 | Sulfacetamide,1TBDMS,isomer #2 | CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N)C=C1 | 2391.6 | Semi standard non polar | 33892256 | Sulfacetamide,1TBDMS,isomer #2 | CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N)C=C1 | 2329.9 | Standard non polar | 33892256 | Sulfacetamide,1TBDMS,isomer #2 | CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N)C=C1 | 3173.9 | Standard polar | 33892256 | Sulfacetamide,2TBDMS,isomer #1 | CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1 | 2788.4 | Semi standard non polar | 33892256 | Sulfacetamide,2TBDMS,isomer #1 | CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1 | 2732.1 | Standard non polar | 33892256 | Sulfacetamide,2TBDMS,isomer #1 | CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N[Si](C)(C)C(C)(C)C)C=C1 | 2802.5 | Standard polar | 33892256 | Sulfacetamide,2TBDMS,isomer #2 | CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1 | 2771.3 | Semi standard non polar | 33892256 | Sulfacetamide,2TBDMS,isomer #2 | CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1 | 2806.4 | Standard non polar | 33892256 | Sulfacetamide,2TBDMS,isomer #2 | CC(=O)NS(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1 | 2772.1 | Standard polar | 33892256 | Sulfacetamide,3TBDMS,isomer #1 | CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1 | 2963.0 | Semi standard non polar | 33892256 | Sulfacetamide,3TBDMS,isomer #1 | CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1 | 3132.8 | Standard non polar | 33892256 | Sulfacetamide,3TBDMS,isomer #1 | CC(=O)N([Si](C)(C)C(C)(C)C)S(=O)(=O)C1=CC=C(N([Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C)C=C1 | 2776.5 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Sulfacetamide GC-MS (Non-derivatized) - 70eV, Positive | splash10-0a4l-9810000000-3ed7ef5d2301b3bc79b4 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Sulfacetamide GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 90V, Negative-QTOF | splash10-004i-0900000000-e5b859bd275f0249f49b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 45V, Negative-QTOF | splash10-004i-1900000000-bcd794de99dec3d4cd4c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 30V, Negative-QTOF | splash10-004i-1900000000-dc03b60aac28b7eaf711 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 75V, Negative-QTOF | splash10-004i-0900000000-bbee625a2449684059ed | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 60V, Negative-QTOF | splash10-004i-0900000000-05ff1f753704f2513572 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 15V, Negative-QTOF | splash10-004i-2900000000-308e3144b1be4d33d976 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 90V, Positive-QTOF | splash10-02di-9100000000-4a8ff5ef6ebcc14cd255 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 75V, Positive-QTOF | splash10-004i-9200000000-4cc7df804333c91fa3f1 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 15V, Positive-QTOF | splash10-0a4i-1900000000-b63a6ce5ca1fab8859c4 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 30V, Positive-QTOF | splash10-0a4i-3900000000-99d02203a7ffbd4085c3 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 60V, Positive-QTOF | splash10-004i-9300000000-2fbaf60f75bc6ea9869d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Sulfacetamide 45V, Positive-QTOF | splash10-056r-9500000000-c80d95695c21e4bb506e | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 10V, Positive-QTOF | splash10-014i-0590000000-b5664e637cd01d75aa3a | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 20V, Positive-QTOF | splash10-05mk-2920000000-7391f4416c0887f99197 | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 40V, Positive-QTOF | splash10-00kf-9200000000-bc9a1ce621f8dc3dfb2d | 2016-08-01 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 10V, Negative-QTOF | splash10-03di-0190000000-35993b29960b01b1cce3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 20V, Negative-QTOF | splash10-0229-1950000000-6034a93912c159eaa0bb | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 40V, Negative-QTOF | splash10-0006-9200000000-f0d12405f0b5fc85b36c | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 10V, Positive-QTOF | splash10-0a4i-0900000000-afdb935daec0bfdc7de6 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 20V, Positive-QTOF | splash10-0006-9000000000-39a4eab401ea01d03e3b | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 40V, Positive-QTOF | splash10-014l-9000000000-12dd58539d3995bd275c | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 10V, Negative-QTOF | splash10-03di-0290000000-58a06de4ad28117dbf13 | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 20V, Negative-QTOF | splash10-03k9-1890000000-f99a02caa8c0b1c3cd2e | 2021-10-11 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Sulfacetamide 40V, Negative-QTOF | splash10-0006-9300000000-e4b5ebbe07e4cdf21bc3 | 2021-10-11 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|